| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 药品研发服务(元) | 342,893,922.28 | 140,255,803.70 | 320,224,524.77 | 170,068,714.66 |
| 医药商品流通(元) | 142,423,322.03 | 75,849,704.53 | 149,881,243.54 | 59,653,812.10 |
| 医药制造业(元) | 1,579,636,718.00 | 776,485,302.36 | 1,475,260,473.54 | 628,951,176.33 |
| 营业成本(元) | ||||
| 药品研发服务(元) | 216,022,440.58 | 101,175,909.59 | 217,594,653.17 | 101,375,333.82 |
| 医药商品流通(元) | 123,947,770.31 | 65,434,335.37 | 134,555,745.16 | 54,450,681.49 |
| 医药制造业(元) | 1,163,786,660.32 | 582,998,238.31 | 1,125,598,408.51 | 492,224,676.71 |
| 毛利(元) | ||||
| 药品研发服务(元) | 126,871,481.70 | 39,079,894.11 | 102,629,871.60 | 68,693,380.84 |
| 医药商品流通(元) | 18,475,551.72 | 10,415,369.16 | 15,325,498.38 | 5,203,130.61 |
| 医药制造业(元) | 415,850,057.68 | 193,487,064.05 | 349,662,065.03 | 136,726,499.62 |
| 毛利率(%) | ||||
| 药品研发服务(%) | 37.00 | 27.86 | 32.05 | 40.39 |
| 医药商品流通(%) | 12.97 | 13.73 | 10.23 | 8.72 |
| 医药制造业(%) | 26.33 | 24.92 | 23.70 | 21.74 |
| 收入构成(%) | ||||
| 药品研发服务(%) | 16.61 | 14.13 | 16.46 | 19.81 |
| 医药商品流通(%) | 6.90 | 7.64 | 7.70 | 6.95 |
| 医药制造业(%) | 76.50 | 78.23 | 75.83 | 73.25 |
| 毛利构成(%) | ||||
| 药品研发服务(%) | 22.61 | 16.08 | 21.95 | 32.61 |
| 医药商品流通(%) | 3.29 | 4.29 | 3.28 | 2.47 |
| 医药制造业(%) | 74.10 | 79.63 | 74.78 | 64.92 |